Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Dollar change +0.0081
Percentage change 1.15	%

Held by: VTI PBW IWM VXF IWO VTWO MOON IWC VTWG IWN

Index	RUT	P/E	-	EPS (ttm)	-1.61	Insider Own	2.55%	Shs Outstand	208.13M	Perf Week	-1.55%
Market Cap	148.54M	Forward P/E	-	EPS next Y	-0.24	Insider Trans	0.09%	Shs Float	202.81M	Perf Month	-7.29%
Income	-204.58M	PEG	-	EPS next Q	-0.20	Inst Own	45.43%	Short Float	24.20%	Perf Quarter	-25.27%
Sales	14.14M	P/S	10.51	EPS this Y	54.97%	Inst Trans	-2.44%	Short Ratio	9.37	Perf Half Y	-40.53%
Book/sh	-0.71	P/B	-	EPS next Y	70.36%	ROA	-160.23%	Short Interest	49.08M	Perf Year	-66.80%
Cash/sh	0.17	P/C	4.32	EPS next 5Y	-	ROE	-	52W Range	0.61 - 5.66	Perf YTD	-34.52%
Dividend Est.	-	P/FCF	-	EPS past 5Y	45.32%	ROI	-356.27%	52W High	-87.40%	Beta	2.23
Dividend TTM	-	Quick Ratio	1.02	Sales past 5Y	556.22%	Gross Margin	-544.00%	52W Low	17.00%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	1.34	EPS Y/Y TTM	60.12%	Oper. Margin	-1055.88%	RSI (14)	44.29	Volatility	12.01% 11.87%
Employees	420	Debt/Eq	-	Sales Y/Y TTM	-39.71%	Profit Margin	-1446.38%	Recom	1.75	Target Price	5.14
Option/Short	Yes / No	LT Debt/Eq	-	EPS Q/Q	71.88%	Payout	-	Rel Volume	3.66	Prev Close	0.71
Sales Surprise	-2.51%	EPS Surprise	-2.22%	Sales Q/Q	-25.29%	Earnings	May 14 AMC	Avg Volume	5.24M	Price	0.71
SMA20	-2.57%	SMA50	-18.11%	SMA200	-51.64%	Trades		Volume	19,172,962	Change	1.15%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-05-23	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-01-23	Upgrade	Guggenheim	Neutral → Buy	$10
Jun-30-23	Downgrade	B. Riley Securities	Buy → Neutral	$3 → $4
Jun-02-23	Initiated	TD Cowen	Market Perform	$2.50
Dec-02-22	Initiated	Stifel	Buy	$11
Mar-22-22	Initiated	Guggenheim	Neutral
Feb-28-22	Reiterated	B. Riley Securities	Buy	$14 → $13
Nov-22-21	Initiated	Evercore ISI	Outperform	$21
Nov-11-21	Initiated	The Benchmark Company	Hold
Sep-17-21	Initiated	Johnson Rice	Buy	$20
Jul-15-21	Initiated	Seaport Global Securities	Buy	$27

Show Previous Ratings

May-16-24 03:03AM	Eos Energy Enterprises Inc (EOSE) (Q1 2024) Earnings Call Transcript Highlights: Key Financial ... (GuruFocus.com)
May-14-24 08:57PM	EOSE Stock Earnings: Eos Energy Enterprises Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) +13.86%
05:15PM	Eos Energy Enterprises, Inc. (EOSE) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:02PM	Eos Energy Enterprises Reports First Quarter 2024 Financial Results and Announces Successful Completion of Factory Acceptance Testing (GlobeNewswire)
May-09-24 07:30AM	Eos Energy Enterprises Announces Participation in Upcoming Investor Conferences (GlobeNewswire) +5.13%
10:00AM	Loading…
May-07-24 10:00AM	Eos Energy Enterprises, Inc. (EOSE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks) -9.44%
May-03-24 08:30AM	Eos Energy Announces Approval of All Proposals at 2024 Annual Stockholder Meeting (GlobeNewswire) +7.67%
Apr-23-24 08:15AM	Eos Energy Enterprises Provides Business Update (GlobeNewswire)
Apr-01-24 08:00AM	Eos Energy and Pine Gate Renewables Sign Agreement to Expand Existing Relationship (GlobeNewswire)
Mar-07-24 11:53AM	Eos Energy Enterprises, Inc. (NASDAQ:EOSE) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 11:52AM	Eos Energy (EOSE) Q4 Earnings Beat Estimates, Revenues Up Y/Y (Zacks)
Mar-04-24 07:51PM	EOSE Stock Earnings: Eos Energy Enterprises Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:53PM	Eos Energy Enterprises Inc Reports Improved Margins and Outlook for 2024 (GuruFocus.com)
04:01PM	Eos Energy Enterprises Reports Fourth Quarter & Full Year 2023 Financial Results and Provides 2024 Outlook (GlobeNewswire)
Feb-29-24 09:00AM	Why Eos Energy (EOSE) Might Surprise This Earnings Season (Zacks)
04:30PM	Loading…
Feb-26-24 04:30PM	Eos Energy Enterprises Announces Dates for Fourth Quarter & Full Year 2023 Financial Results (GlobeNewswire)
Feb-21-24 05:00PM	Car Tech, LLC and AltEnergy Acquisition Corp Announce Definitive Business Combination Agreement to List Merged Company on the NASDAQ Capital Market (PR Newswire)
Feb-13-24 08:30AM	Eos Energy Enterprises Achieves Power On Status of all Motion Systems on its First State-of-the-Art Manufacturing Line and Provides Preliminary Results (GlobeNewswire) -12.56%
Feb-01-24 08:30AM	Eos Energy Enterprises Join Forces with SABIC Specialties to Produce a Specialty Light-Weight, Conductive Composite Thermoplastic for Eos Z3TM Battery (GlobeNewswire) +12.61%
Jan-09-24 07:30AM	Eos Energy Enterprises and TETRA Technologies, Inc. Extend Partnership, Expanding Electrolyte Production Capacity (GlobeNewswire)
Dec-20-23 07:30AM	Eos Energy and Partner4Work Collaborate on Green Technology Career Development (GlobeNewswire)
Dec-14-23 07:18PM	Eos Energy Announces Pricing of $50 Million Public Offering (GlobeNewswire) +13.51%
04:26PM	Eos Energy Announces Launch of Proposed $40M Public Offering (GlobeNewswire)
Dec-12-23 04:30PM	Eos Energy and Pine Gate Renewables Announce Partnership Expansion (GlobeNewswire) -6.67%
Dec-05-23 07:30AM	Eos Energy Enterprises Confirms Timing for Strategic Outlook Call (GlobeNewswire)
Nov-06-23 05:40PM	Eos Energy Enterprises Inc (EOSE) Reports Q3 2023 Financial Results (GuruFocus.com) -9.14%
04:15PM	Eos Energy Enterprises Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-25-23 06:30AM	Eos Energy Enterprises Confirms Timing for Third Quarter 2023 Financial Results Call and Upcoming Event Participation (GlobeNewswire)
Oct-10-23 06:30AM	Eos Energy Enterprises Announces Dates for Third Quarter 2023 Financial Results and Strategic Update Call (GlobeNewswire) +5.85%
Oct-06-23 10:30AM	Eos Energy Enterprises Appoints Jeff McNeil to Board of Directors (GlobeNewswire) +7.25%
10:49AM	Loading…
Sep-19-23 10:49AM	Local battery makers win share of big renewable energy power project (American City Business Journals) +5.26%
10:00AM	Eos Z3 Energy Storage System Selected by Dominion Energy Virginia for Groundbreaking New Pilot Project (GlobeNewswire)
10:00AM	Dominion Energy explores pioneering battery storage technologies in Virginia (PR Newswire)
Sep-18-23 09:00AM	Eos Energy Enterprises Announces Upcoming Investor and Industry Event Participation (GlobeNewswire) -11.97%
Sep-01-23 10:03AM	Eos Energy Stock Surges After Battery Storage Startup Gets Government Loan Commitment (The Wall Street Journal) +18.46%
10:00AM	MercadoLibre upgraded, PagerDuty downgraded: Wall Street's top analyst calls (The Fly)
Aug-31-23 04:00PM	Eos Energy Enterprises Announces Project AMAZE, a $500M Program to Address Long-Duration Energy Storage Demand (GlobeNewswire)
Aug-24-23 09:00AM	Eos Energy Enterprises Partners with ACRO Automation, Inc. (GlobeNewswire) -5.79%
Aug-14-23 04:44PM	Eos Energy Enterprises Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-31-23 06:44AM	Daily Vickers Top Buyers & Sellers for 07/31/2023 (Argus Research) +8.85%
Jul-27-23 08:11PM	Eos Energy Enterprises Provides Preliminary Results & Issues Statement Regarding Its Customer Commitments and Backlog (GlobeNewswire) -23.85%
Jun-01-23 04:30PM	Eos Energy Enterprises Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
May-15-23 09:00AM	Eos Energy Enterprises, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -5.33%
May-09-23 04:30PM	Eos Energy Enterprises Reports First Quarter 2023 Financial Results (GlobeNewswire) -6.25%
Apr-25-23 04:30PM	Eos Energy Enterprises Announces First Quarter 2023 Financial Results Release and Conference Call (GlobeNewswire) -9.95%
Apr-12-23 09:31AM	Eos Energy Enterprises, Inc. Announces $40 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -16.61%
Feb-28-23 06:24PM	Eos Energy Enterprises Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-16-23 04:28PM	Eos Energy Enterprises Announces Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call (GlobeNewswire) +8.51%
Feb-08-23 06:13AM	Eos Energy Enterprises (NASDAQ:EOSE) investors are sitting on a loss of 62% if they invested a year ago (Simply Wall St.)
Feb-02-23 08:45AM	Eos Energy Enterprises, Inc. Provides Business Update (GlobeNewswire) -8.90%
Jan-23-23 08:59AM	Eos Energy Enterprises, Inc. Announces CFO Transition (GlobeNewswire)
Jan-19-23 04:30PM	Eos Energy Enterprises, Inc. Announces $13.75 Million Investment from Existing Investors (GlobeNewswire)
Nov-07-22 04:01PM	Eos Energy Enterprises Reports Third Quarter 2022 Financial Results (GlobeNewswire) +6.54%
Nov-04-22 09:12AM	Eos Energy Enterprises, Inc. Selected for 35 MWh Long Duration Energy Storage Project in California (GlobeNewswire)
Oct-31-22 06:15AM	Inflation Reduction Act Offers Opportunity for Eos Energy Enterprises, Inc. and Energy Storage Customers to Capture Substantial Long-Term Value While Significantly Reducing Emissions (GlobeNewswire) +9.15%
Oct-25-22 08:15AM	Eos Energy Enterprises Announces Third Quarter 2022 Financial Results Release and Conference Call (GlobeNewswire) +10.79%
Sep-13-22 12:42PM	U.S. Department of Energy Loan Programs Office Invites Eos Energy Enterprises, Inc. Into Due Diligence (GlobeNewswire)
Sep-09-22 07:00AM	Eos Energy Enterprises Appoints Jeff Bornstein to Board of Directors (GlobeNewswire) +7.37%
Sep-01-22 05:27PM	Verdant Microgrid, LLC Announces Completion of New Microgrid at ThermalVac Technologies, Inc. in Orange, California (PR Newswire) -5.83%
Aug-31-22 04:55PM	Top Penny Stocks for September 2022 (Investopedia)
Aug-05-22 05:27PM	Eos Energy Enterprises, Inc. Borrows Additional $9.6 Million Under Previously Announced Credit Facility (GlobeNewswire) +17.36%
06:20AM	Analysts Have Been Trimming Their Eos Energy Enterprises, Inc. (NASDAQ:EOSE) Price Target After Its Latest Report (Simply Wall St.)
Aug-02-22 06:00AM	Eos Energy Enterprises Reports Second Quarter 2022 Financial Results (GlobeNewswire) -11.18%
Aug-01-22 07:00AM	Eos Energy Enterprises, Inc. Secures $85 million Term Loan Credit Facility to Fund Growth (GlobeNewswire)
Jul-28-22 11:44AM	Insiders at Eos Energy Enterprises, Inc. (NASDAQ:EOSE) snagged a bargain: a US$140k profit on a US$731k buy (Simply Wall St.) +12.08%
Jul-27-22 08:37AM	Eos Announces Second Quarter 2022 Financial Results Release and Conference Call; Participation in Upcoming Investor Conference (GlobeNewswire) +14.29%
Jul-25-22 08:01AM	SmileDirectClub Announces Appointment of Alex Dimitrief to Board of Directors (GlobeNewswire) -7.26%
Jul-22-22 10:26AM	Eos Energy Enterprises Inc. Establishes Eos Ingenuity Lab at Edison, NJ Headquarters (GlobeNewswire) -19.31%
Jul-06-22 08:41AM	Eos Energy Enterprises, Inc. Secures Over 1 GWh in New Orders, More Than Doubles Backlog to Over $460 Million (GlobeNewswire) +13.49%
Jun-23-22 08:39AM	Eos Energy Enterprises, Inc. Continues to Achieve Manufacturing and Operational Milestones (GlobeNewswire)
May-31-22 03:01PM	Eos Energy Enterprises, Inc. Announces Participation in Upcoming Investor Conferences (GlobeNewswire) -8.00%
May-10-22 06:00AM	Eos Energy Enterprises Reports First Quarter 2022 Financial Results (GlobeNewswire) -14.66%
May-03-22 01:00PM	Eos Energy CEO Joe Mastrangelo Selected as an EY Entrepreneur of The Year® 2022 New Jersey Award Finalist (GlobeNewswire)
May-02-22 06:15PM	Eos Energy Announces First Quarter 2022 Financial Results Release and Conference Call; Participation in Upcoming Investor Conferences (GlobeNewswire)
Apr-28-22 04:42PM	Eos Energy Enterprises Secures $200 million Financing Commitment (GlobeNewswire) +6.05%
Apr-19-22 09:15AM	Eos Energy Enterprises Clarifies Details Regarding 8-K Filing (GlobeNewswire)
Mar-09-22 08:30AM	Eos Energy Enterprises Secures Record-Breaking Order from Bridgelink Commodities, LLC (GlobeNewswire)
Mar-04-22 10:14AM	EOS Energy Jumps 26% on Insider Buying Spree (GuruFocus.com) +8.01%
Feb-25-22 06:00AM	Eos Energy Enterprises Reports Fourth Quarter and Full Year 2021 Financial Results and Announces 2022 Outlook (GlobeNewswire)
Feb-24-22 11:25AM	Eos Energy Enterprises takes more than 100,000 square feet at Keystone Commons (American City Business Journals) +10.25%
08:30AM	Eos Energy Enterprises Invited to Submit Part II Loan Application by U.S. Department of Energy (GlobeNewswire)
Feb-23-22 08:30AM	Eos Energy Enterprises Expands Manufacturing Facility (GlobeNewswire)
Feb-14-22 05:00PM	Eos Energy Enterprises Appoints Chief Accounting Officer (GlobeNewswire)
Feb-11-22 08:00AM	Eos Energy Announces Fourth Quarter and Full Year 2021 Financial Results Release and Conference Call (GlobeNewswire) -8.53%
Jan-04-22 04:15PM	Eos Energy to Participate in Upcoming Investor Conferences (GlobeNewswire) -7.11%
Dec-16-21 05:00PM	EOS ENERGY ENTERPRISES AND TETRA TECHNOLOGIES, INC AGREE TO LONG-TERM RELATIONSHIP FOR EOS' STORAGE TECHNOLOGY (PR Newswire)
Dec-14-21 05:00PM	Eos Energy Enterprises Appoints New Chief Financial Officer (GlobeNewswire)
Dec-13-21 08:30AM	AltEnergy Acquisition Corp.. Announces Separate Trading of its Common Stock and Warrants, Commencing December 13, 2021 (PR Newswire)
Dec-02-21 02:00PM	CEO of Eos Energy Enterprises Applauds House Action and Supports Swift Passage of the Build Back Better Act in the Senate to Jumpstart Domestic Manufacturing (GlobeNewswire)
Nov-23-21 06:57PM	Energy Storage Is the Next Mega Theme; These 2 Stocks Are Poised to Benefit (TipRanks) -5.32%
Nov-10-21 07:05AM	Eos Energy Enterprises Reports Third Quarter 2021 Financial Results (GlobeNewswire)
07:00AM	Eos Energy Enterprises Secures Milestone 300MWh Order from Solar EPC Firm Blue Ridge Power (GlobeNewswire)
Oct-20-21 09:00AM	Eos Energy Announces Third Quarter 2021 Financial Results Release and Conference Call; Participation in Upcoming Investor Conferences (GlobeNewswire)
Oct-15-21 07:45AM	When Will Eos Energy Enterprises, Inc. (NASDAQ:EOSE) Breakeven? (Simply Wall St.)
Oct-05-21 09:00AM	Eos Energy Enterprises Announces $25 Million Equipment Financing Agreement with Trinity Capital Inc. (GlobeNewswire)
Sep-22-21 08:30AM	Eos Energy Enterprises Appoints Chief Technology Officer (GlobeNewswire) +6.36%
Sep-01-21 08:30AM	Eos Energy Enterprises Appoints Claude Demby to Board of Directors (GlobeNewswire) +5.34%
Aug-16-21 07:25AM	What Kind Of Shareholders Hold The Majority In Eos Energy Enterprises, Inc.'s (NASDAQ:EOSE) Shares? (Simply Wall St.)
Aug-11-21 07:00AM	Eos Energy Enterprises Reports Second Quarter 2021 Financial Results and Updated Guidance (GlobeNewswire)
Jul-21-21 08:00AM	Eos Energy Announces Second Quarter 2021 Financial Results Release and Conference Call; Participating in an Upcoming Investor Conference (GlobeNewswire) +5.21%

Eos Energy Enterprises, Inc. designs, manufactures, and deploy safe, scalable, and sustainable, low total cost of ownership battery storage solutions for the electricity industry. Its product Eos Znyth DC battery system designed to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bornstein Jeffrey S	Director	Apr 30 '24	Option Exercise	0.00	32,328	0	114,929	May 02 08:30 PM
Demby Claude	Director	Apr 30 '24	Option Exercise	0.00	32,328	0	94,340	May 02 08:19 PM
McNeil Jeff	Director	Apr 30 '24	Option Exercise	0.00	36,232	0	36,232	May 02 08:17 PM
Stidolph Russell Monoki	Director	Apr 30 '24	Option Exercise	0.00	32,328	0	301,197	May 02 08:15 PM
Zibelman Audrey Ann	Director	Apr 30 '24	Option Exercise	0.00	32,328	0	104,897	May 02 08:12 PM
Walters Marian	Director	Apr 30 '24	Option Exercise	0.00	32,328	0	104,847	May 02 08:09 PM
DIMITRIEF ALEXANDER	Director	Apr 30 '24	Option Exercise	0.00	32,328	0	167,347	May 02 08:06 PM
DIMITRIEF ALEXANDER	Director	Mar 08 '24	Buy	1.13	5,000	5,638	10,000	Mar 12 05:48 PM
Berube Melissa	General Counsel	Jan 27 '24	Option Exercise	0.00	204,657	0	253,068	Jan 30 06:03 PM
Kroeker Nathan	Chief Financial Officer	Jan 23 '24	Option Exercise	0.00	100,000	0	134,260	Jan 25 06:32 PM
Mastrangelo Joe	Chief Executive Officer	Jan 03 '24	Option Exercise	0.00	250,000	0	840,799	Jan 05 07:47 PM
Kroeker Nathan	Chief Financial Officer	Oct 30 '23	Option Exercise	0.00	40,000	0	44,000	Nov 01 08:58 PM
Mastrangelo Joe	Chief Executive Officer	Sep 21 '23	Buy	2.05	36,500	74,810	590,799	Sep 21 12:45 PM
Demby Claude	Director	Sep 07 '23	Sale	2.78	20,143	55,998	62,012	Sep 08 04:52 PM
Mastrangelo Joe	Chief Executive Officer	Jul 28 '23	Buy	2.23	31,199	69,574	554,299	Jul 28 05:45 PM
DIMITRIEF ALEXANDER	Director	Jul 28 '23	Buy	2.13	5,000	10,641	5,000	Aug 01 05:45 PM
Kroeker Nathan	Chief Financial Officer	Jul 28 '23	Buy	2.15	4,000	8,582	4,000	Jul 28 05:43 PM
Berube Melissa	General Counsel	Jun 15 '23	Option Exercise	0.00	25,000	0	56,524	Jun 16 04:46 PM

Open in Screener

ALVR

AlloVir Inc

May 17 • 04:00PM ET

0.7754

Dollar change +0.0240
Percentage change 3.19	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN SCHA VTWO IWC FESM VTWV URTY

Index	RUT	P/E	-	EPS (ttm)	-1.66	Insider Own	51.81%	Shs Outstand	113.97M	Perf Week	-1.29%
Market Cap	89.17M	Forward P/E	-	EPS next Y	-0.31	Insider Trans	-0.32%	Shs Float	55.42M	Perf Month	4.49%
Income	-179.53M	PEG	-	EPS next Q	-0.24	Inst Own	43.01%	Short Float	12.13%	Perf Quarter	10.77%
Sales	0.00M	P/S	-	EPS this Y	75.84%	Inst Trans	24.79%	Short Ratio	14.01	Perf Half Y	-53.85%
Book/sh	1.05	P/B	0.74	EPS next Y	29.12%	ROA	-92.50%	Short Interest	6.72M	Perf Year	-81.32%
Cash/sh	1.22	P/C	0.63	EPS next 5Y	-	ROE	-114.36%	52W Range	0.58 - 6.12	Perf YTD	14.06%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-70.96%	ROI	-131.54%	52W High	-87.33%	Beta	0.77
Dividend TTM	-	Quick Ratio	18.48	Sales past 5Y	-37.09%	Gross Margin	-	52W Low	33.69%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	18.48	EPS Y/Y TTM	18.82%	Oper. Margin	0.00%	RSI (14)	49.99	Volatility	12.74% 6.08%
Employees	112	Debt/Eq	0.15	Sales Y/Y TTM	-	Profit Margin	-	Recom	4.25	Target Price	0.80
Option/Short	Yes / Yes	LT Debt/Eq	0.13	EPS Q/Q	40.14%	Payout	-	Rel Volume	0.38	Prev Close	0.75
Sales Surprise	-	EPS Surprise	-4.89%	Sales Q/Q	-	Earnings	Nov 02 BMO	Avg Volume	480.04K	Price	0.78
SMA20	-1.31%	SMA50	1.36%	SMA200	-47.36%	Trades		Volume	183,904	Change	3.19%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-26-23	Downgrade	BofA Securities	Buy → Underperform	$17 → $1
Dec-22-23	Downgrade	Piper Sandler	Overweight → Neutral
Dec-22-23	Downgrade	Leerink Partners	Outperform → Market Perform
Dec-22-23	Downgrade	JP Morgan	Overweight → Underweight
Aug-18-23	Initiated	BofA Securities	Buy	$17
Oct-19-21	Resumed	Morgan Stanley	Overweight	$48
Aug-24-20	Initiated	SVB Leerink	Outperform	$41
Aug-24-20	Initiated	Morgan Stanley	Overweight	$49
Aug-24-20	Initiated	JP Morgan	Overweight	$50

May-14-24 08:53AM	ALVR Stock Earnings: AlloVir Misses EPS for Q1 2024 (InvestorPlace)
Mar-18-24 03:53PM	ALVR Stock Earnings: AlloVir Misses EPS for Q4 2023 (InvestorPlace) -6.03%
Mar-13-24 11:53AM	AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights ALVR (GlobeNewswire)
10:00AM	SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allovir (PR Newswire)
Mar-12-24 05:50AM	AlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVR (PR Newswire)
06:17PM	Loading…
Mar-06-24 06:17PM	ALVR INVESTORS: Lead Plaintiff Deadline is Approaching; Contact Robbins LLP for Information About Your Rights (GlobeNewswire)
Mar-04-24 05:37PM	AlloVir, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; March 19, 2024 deadline (GlobeNewswire)
Feb-28-24 01:06AM	AlloVir, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; March 19, 2024 deadline (GlobeNewswire)
Feb-27-24 08:00AM	Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise (Newsfile)
Feb-26-24 12:27PM	AlloVir, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky for More Information ALVR (GlobeNewswire)
Feb-23-24 10:30AM	ALLOVIR SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-29-24 09:40AM	Are Medical Stocks Lagging AlloVir (ALVR) This Year? (Zacks)
Jan-24-24 09:45AM	ALLOVIR SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-12-24 09:35AM	Down -72.39% in 4 Weeks, Here's Why You Should You Buy the Dip in AlloVir, Inc. (ALVR) (Zacks) +5.30%
Jan-05-24 11:03AM	AlloVir Layoffs 2024: What to Know About the Latest ALVR Job Cuts (InvestorPlace)
08:37AM	Loading…
08:37AM	Reeling from triple phase 3 failure, AlloVir cuts 95% of workforce (FierceBiotech.com)
Dec-26-23 10:04AM	Karuna downgraded, Arm target raised: Wall Street's top analyst calls (The Fly)
Dec-22-23 09:31AM	Nike downgraded, Waste Management upgraded: Wall Street's top analyst calls (The Fly) -67.15%
08:30AM	AlloVir's shares plunge 64% as cell therapy biotech weighs options in wake of triple phase 3 disaster (FierceBiotech.com)
07:10AM	AlloVir scraps late-stage studies testing antiviral cell therapy (Reuters)
07:00AM	AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy (GlobeNewswire)
Dec-05-23 08:55AM	Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential (InvestorPlace)
Nov-16-23 07:00AM	AlloVir to Present at the Piper Sandler 35th Annual Healthcare Conference (Business Wire)
Nov-02-23 10:04AM	AlloVir Inc (ALVR) Reports Q3 2023 Financial Results (GuruFocus.com) +13.64%
07:00AM	AlloVir Reports Third Quarter 2023 Financial Results (Business Wire)
Sep-21-23 02:44PM	Why AlloVir Stock Dropped Today (Motley Fool)
Sep-14-23 09:59AM	These 2 Strong Buy Penny Stocks Could Soar to $17 (Or Higher), Say Analysts (TipRanks) +9.72%
Aug-28-23 07:00AM	AlloVir to Present at Upcoming Investor Conferences (Business Wire) +7.00%
Aug-03-23 07:00AM	AlloVir Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-21-23 07:17AM	Eliem (ELYM) to Explore Strategic Options, Stock Rises 6% (Zacks) +7.55%
03:12AM	Loading…
Jul-12-23 03:12AM	Gilead Just Bought $30 Million More of 2 Biotech Stocks (Barrons.com) +6.76%
Jul-04-23 07:34AM	Journey Medical (DERM) to Post Skin Disease Data, Stock Rises 26% (Zacks)
Jul-03-23 03:59AM	5 hot insider trades & hedge fund hits: Buffett picks up more Occidental shares (Investing.com)
Jun-27-23 12:00PM	AlloVir, Inc. (ALVR) Upgraded to Buy: Here's Why (Zacks)
Jun-23-23 01:56PM	Why Shares of AlloVir Plummeted This Week (Motley Fool)
Jun-21-23 09:20PM	AlloVir Announces Pricing of Public Offering of Common Stock (Business Wire)
04:18PM	AlloVir Announces Proposed Public Offering of Common Stock (Business Wire)
Jun-09-23 11:04AM	Why Shares of AlloVir Jumped This Week (Motley Fool) -7.83%
Jun-05-23 07:00AM	AlloVir Presents Positive Final Results From A Phase 2 Randomized, Placebo-Controlled Trial Evaluating Posoleucel Treatment of BK Infection in Kidney Transplant Recipients at the American Transplant Congress (ATC 2023) (Business Wire) +12.63%
May-16-23 07:00AM	AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer (Business Wire)
May-04-23 07:00AM	AlloVir Reports First Quarter 2023 Financial Results (Business Wire) +10.36%
May-01-23 07:00AM	AlloVir to Present at the BofA Securities 2023 Health Care Conference (Business Wire) +8.14%
Apr-26-23 05:12PM	AlloVir's Posoleucel Achieves Non-Relapse Mortality Of 0% In Transplant Patients For Viral Infections (Benzinga)
07:00AM	AlloVir Announces Positive Results Including Long-Term Mortality Data in Phase 2 Posoleucel Multi-Virus Prevention Study in Oral Presentation at EBMT 2023 (Business Wire)
Mar-30-23 11:12AM	We Think AlloVir (NASDAQ:ALVR) Needs To Drive Business Growth Carefully (Simply Wall St.) -5.67%
Feb-23-23 04:15PM	AlloVir Appoints Derek Adams, Ph.D., to Board of Directors (Business Wire) +7.14%
Feb-15-23 10:05AM	AlloVir Announces Final Results From Posoleucel Study In Kidney Transplant Recipients With BK Viremia, Shares Fall (Benzinga) -5.17%
07:07AM	AlloVir Reports Full-Year 2022 Financial Results and 2023 Outlook (Business Wire)
07:00AM	AlloVir Announces Positive Final Results from Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Posoleucel in Kidney Transplant Recipients with BK Viremia (Business Wire)
Feb-10-23 09:55AM	Wall Street Analysts Predict a 281.43% Upside in AlloVir, Inc. (ALVR): Here's What You Should Know (Zacks)
Feb-07-23 10:17AM	Sage and Biogen's NDA for Depression Drug Gets Priority Review (Zacks)
Feb-01-23 07:00AM	AlloVir to Participate in the SVB Securities Global Biopharma Conference (Business Wire)
Jan-25-23 12:00PM	AlloVir, Inc. (ALVR) Upgraded to Buy: Here's What You Should Know (Zacks)
09:55AM	How Much Upside is Left in AlloVir, Inc. (ALVR)? Wall Street Analysts Think 355.8% (Zacks)
09:40AM	Are Medical Stocks Lagging Adicet Bio (ACET) This Year? (Zacks)
Jan-09-23 07:00AM	AlloVir Announces Plans to Complete Enrollment in Three Phase 3 Posoleucel Studies in 2023 (Business Wire)
Jan-03-23 07:00AM	AlloVir to Present at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-10-22 05:15PM	AlloVir Announces Positive Final Results in Phase 2 Posoleucel Multi-Virus Prevention Study In Oral Presentation at the 64th ASH Annual Meeting and Exposition (Business Wire)
Nov-15-22 07:00AM	AlloVir to Participate in the Piper Sandler 34th Annual Healthcare Conference (Business Wire) -5.21%
Nov-03-22 09:07AM	Final Data from AlloVirs Phase 2 Study of Posoleucel for Multi-Virus Prevention to be Highlighted in Oral Presentation at 64th American Society of Hematology Annual Meeting (Business Wire)
07:00AM	AlloVir Reports Third Quarter 2022 Financial Results (Business Wire)
Oct-21-22 08:30AM	We Think AlloVir (NASDAQ:ALVR) Needs To Drive Business Growth Carefully (Simply Wall St.)
Sep-06-22 09:55AM	Wall Street Analysts See a 259% Upside in AlloVir, Inc. (ALVR): Can the Stock Really Move This High? (Zacks) -5.10%
Aug-31-22 07:00AM	AlloVir to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference (Business Wire) +19.97%
Aug-19-22 09:55AM	Does AlloVir, Inc. (ALVR) Have the Potential to Rally 251% as Wall Street Analysts Expect? (Zacks)
Aug-04-22 07:00AM	AlloVir Reports Second Quarter 2022 Financial Results (Business Wire) +12.22%
Aug-03-22 09:55AM	Wall Street Analysts Predict a 447% Upside in AlloVir, Inc. (ALVR): Here's What You Should Know (Zacks) +5.06%
Aug-01-22 08:09AM	Do Institutions Own AlloVir, Inc. (NASDAQ:ALVR) Shares? (Simply Wall St.)
Jul-27-22 07:00AM	AlloVir Announces $126.6 Million Registered Direct Offering (Business Wire) +11.93%
Jun-07-22 12:07PM	AlloVir's Posoleucel Shows Early Safety In Kidney Transplant Recipients (Benzinga)
08:30AM	AlloVir Reports Blinded, Preliminary, Phase 2 Data Supporting the Ongoing Study of Posoleucel, a Multi-Virus-Specific T Cell Therapy, for the Treatment of BK Viremia in Kidney Transplant Recipients (Business Wire)
May-05-22 07:00AM	AlloVir Reports First Quarter 2022 Financial Results (Business Wire)
Apr-21-22 11:35AM	AlloVir (ALVR) Up on Third RMAT Status From FDA for Posoleucel (Zacks) -13.28%
Apr-20-22 07:00AM	FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVirs Posoleucel for Prevention of Multiple Life-Threatening Infections from Six Viruses in Allogeneic Hematopoietic Cell Transplant Patients (Business Wire) +15.53%
Apr-04-22 07:40PM	Here's Why We're Watching AlloVir's (NASDAQ:ALVR) Cash Burn Situation (Simply Wall St.)
Mar-31-22 07:00AM	AlloVir Appoints Shawn Tomasello to Its Board of Directors (Business Wire) -6.77%
Mar-23-22 09:56AM	AlloVir (ALVR) Begins Study to Prevent Six Viral Infections (Zacks)
Mar-22-22 07:00AM	AlloVir Initiates Global Phase 3 Registrational Study of Posoleucel for Prevention of Life-Threatening Viral Infections from Six Common Viruses in High-Risk, Allogeneic Hematopoietic Cell Transplant Patients (Business Wire) +7.25%
Feb-11-22 07:00AM	AlloVir to Participate in the 11th Annual SVB Leerink Global Healthcare Conference (Business Wire)
Feb-10-22 07:00AM	AlloVir Reports Full-Year 2021 Financial Results and 2022 Outlook (Business Wire)
Jan-05-22 07:30AM	FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to AlloVirs Posoleucel for the Treatment of Adenovirus (AdV) Infections in Adults and Children Post-Allogeneic Stem Cell Transplantation (Business Wire)
Jan-03-22 04:05PM	AlloVir to Present at the 40th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-16-21 04:05PM	AlloVir Announces Departure of Chief Medical Officer Augustin Melian (Business Wire) -6.32%
Dec-11-21 01:00PM	AlloVir Announces Positive Preliminary Data from the Ongoing Phase 2 Posoleucel Multi-Virus Prevention Study at the 63rd American Society of Hematology Annual Meeting (Business Wire)
Nov-17-21 11:57AM	Allovir Insider Sold Over $465K In Company Stock (Benzinga)
Nov-15-21 07:00AM	AlloVir to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference (Business Wire)
Nov-10-21 11:48AM	Allovir Insider Trades $300K In Company Stock (Benzinga)
Nov-05-21 07:00AM	AlloVir Reports Third Quarter 2021 Financial Results (Business Wire)
Oct-29-21 09:47AM	Morgan Stanley: These 2 Strong Buy Stocks Could Double From Here (TipRanks)
Oct-06-21 11:31AM	Notable Allovir Insider Makes $445K Sale (Benzinga)
Oct-05-21 06:48AM	Companies Like AlloVir (NASDAQ:ALVR) Are In A Position To Invest In Growth (Simply Wall St.)
Oct-04-21 07:00AM	FDA Grants Orphan Drug Designation (ODD) to AlloVirs Posoleucel, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy, for the Treatment of Virus-Associated Hemorrhagic Cystitis (Business Wire) -12.20%
Sep-29-21 02:09PM	Hedge Funds Are Buying AlloVir, Inc. (ALVR) (Insider Monkey)
07:00AM	Data Presented at IDWeek 2021 Demonstrate that ALVR109, AlloVirs Investigational SARS-CoV-2-Specific T Cell Therapy, Is Reactive Against a Broad Range of Variants, Including Delta (Business Wire)
Sep-07-21 07:00AM	AlloVir to Present at the Morgan Stanley 19th Annual Global Healthcare Conference (Business Wire)
Sep-03-21 08:19AM	Biotech Is Due for a Comeback. 5 Stocks That Could Lead a Revival. (Barrons.com)
Aug-26-21 01:41PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Avalara, Inc. - ALVR (Newsfile)
Aug-06-21 07:00AM	AlloVir Reports Second Quarter 2021 Financial Results (Business Wire)
Jun-27-21 03:19AM	Should You Take Comfort From Insider Transactions At AlloVir, Inc. (NASDAQ:ALVR)? (Simply Wall St.)
May-06-21 07:00AM	AlloVir Reports First Quarter 2021 Financial Results (Business Wire)

AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brainard Diana	Chief Executive Officer	May 03 '24	Sale	0.80	10,240	8,151	792,695	May 07 04:15 PM
Sinha Vikas	See Remarks	May 03 '24	Sale	0.80	4,957	3,946	1,133,139	May 07 04:15 PM
Miller Edward	General Counsel	May 03 '24	Sale	0.80	2,311	1,840	220,916	May 07 04:15 PM
Hagen Brett R	Chief Accounting Officer	May 03 '24	Sale	0.80	1,597	1,271	76,022	May 07 04:15 PM
Sinha Vikas	See Remarks	Apr 22 '24	Sale	0.75	1,857	1,393	1,138,096	Apr 23 04:15 PM
Miller Edward	General Counsel	Apr 22 '24	Sale	0.75	757	568	223,227	Apr 23 04:15 PM
Hagen Brett R	Chief Accounting Officer	Apr 22 '24	Sale	0.75	480	360	77,619	Apr 23 04:15 PM
Brainard Diana	Chief Executive Officer	Apr 19 '24	Sale	0.75	9,601	7,207	802,935	Apr 23 04:15 PM
Sinha Vikas	See Remarks	Apr 19 '24	Sale	0.75	1,521	1,142	1,139,953	Apr 23 04:15 PM
Miller Edward	General Counsel	Apr 19 '24	Sale	0.75	626	470	223,984	Apr 23 04:15 PM
Hagen Brett R	Chief Accounting Officer	Apr 19 '24	Sale	0.75	473	355	78,099	Apr 23 04:15 PM
Brainard Diana	Chief Executive Officer	Apr 02 '24	Sale	0.77	1,533	1,183	812,536	Apr 04 04:15 PM
Sinha Vikas	See Remarks	Apr 02 '24	Sale	0.77	885	683	1,141,474	Apr 04 04:15 PM
Miller Edward	General Counsel	Apr 02 '24	Sale	0.77	368	284	224,610	Apr 04 04:15 PM
Hagen Brett R	Chief Accounting Officer	Apr 02 '24	Sale	0.77	281	217	78,572	Apr 04 04:15 PM
Brainard Diana	Chief Executive Officer	Feb 21 '24	Sale	0.71	5,155	3,650	814,069	Feb 22 04:18 PM
Brainard Diana	Chief Executive Officer	Feb 20 '24	Sale	0.70	3,097	2,153	819,224	Feb 22 04:18 PM
Sinha Vikas	See Remarks	Feb 20 '24	Sale	0.70	2,893	2,011	1,142,359	Feb 22 04:15 PM
Hagen Brett R	Chief Accounting Officer	Feb 20 '24	Sale	0.70	494	343	78,853	Feb 22 04:15 PM
Miller Edward	General Counsel	Feb 20 '24	Sale	0.70	385	268	224,978	Feb 22 04:16 PM
Hagen Brett R	Chief Accounting Officer	Feb 08 '24	Sale	0.67	11,150	7,494	79,347	Feb 09 08:01 PM
Brainard Diana	Chief Executive Officer	Feb 05 '24	Sale	0.67	41,421	27,752	822,321	Feb 06 04:38 PM
Sinha Vikas	See Remarks	Feb 05 '24	Sale	0.67	18,331	12,282	1,145,252	Feb 06 04:46 PM
Miller Edward	General Counsel	Feb 05 '24	Sale	0.67	8,869	5,942	225,363	Feb 06 04:40 PM
Hagen Brett R	Chief Accounting Officer	Feb 05 '24	Sale	0.67	5,792	3,881	90,497	Feb 06 04:39 PM
Brainard Diana	Chief Executive Officer	Jan 23 '24	Sale	0.67	9,500	6,369	863,742	Jan 25 04:15 PM
Sinha Vikas	See Remarks	Jan 23 '24	Sale	0.67	3,205	2,150	1,163,583	Jan 25 04:15 PM
Miller Edward	General Counsel	Jan 23 '24	Sale	0.67	1,302	873	234,232	Jan 25 04:15 PM
Hagen Brett R	Chief Accounting Officer	Jan 23 '24	Sale	0.67	901	604	96,289	Jan 25 04:15 PM
Brainard Diana	Chief Executive Officer	Jan 04 '24	Sale	0.64	1,664	1,063	873,242	Jan 08 04:15 PM
Sinha Vikas	See Remarks	Jan 04 '24	Sale	0.64	961	614	1,166,788	Jan 08 04:15 PM
Miller Edward	General Counsel	Jan 04 '24	Sale	0.64	424	271	235,534	Jan 08 04:15 PM
Hagen Brett R	Chief Accounting Officer	Jan 04 '24	Sale	0.64	310	198	97,190	Jan 08 04:15 PM
Hagen Brett R	Chief Accounting Officer	Dec 27 '23	Sale	0.74	28,335	20,838	97,500	Jan 02 07:36 PM
Brainard Diana	Chief Executive Officer	Nov 20 '23	Sale	1.69	4,382	7,408	874,906	Nov 21 05:00 PM
Brainard Diana	Chief Executive Officer	Nov 17 '23	Sale	1.63	2,689	4,386	879,288	Nov 21 05:00 PM
Sinha Vikas	See Remarks	Nov 17 '23	Sale	1.63	2,490	4,061	1,167,749	Nov 21 05:00 PM
Hagen Brett R	Chief Accounting Officer	Nov 17 '23	Sale	1.63	403	657	125,835	Nov 21 05:00 PM
Sinha Vikas	See Remarks	Oct 20 '23	Sale	1.54	1,475	2,273	1,170,239	Oct 23 05:00 PM
Hagen Brett R	Chief Accounting Officer	Oct 20 '23	Sale	1.54	357	550	126,238	Oct 23 05:00 PM
Brainard Diana	Chief Executive Officer	Oct 19 '23	Sale	1.58	8,581	13,558	881,977	Oct 23 05:00 PM
Sinha Vikas	See Remarks	Oct 19 '23	Sale	1.58	1,232	1,947	1,171,714	Oct 23 05:00 PM
Hagen Brett R	Chief Accounting Officer	Oct 19 '23	Sale	1.58	358	566	126,595	Oct 23 05:00 PM
Brainard Diana	Chief Executive Officer	Oct 03 '23	Sale	1.98	1,325	2,619	890,558	Oct 05 05:00 PM
Sinha Vikas	See Remarks	Oct 03 '23	Sale	1.98	755	1,492	1,172,946	Oct 05 05:00 PM
Hagen Brett R	Chief Accounting Officer	Oct 03 '23	Sale	1.98	222	439	126,953	Oct 05 05:00 PM
Brainard Diana	Chief Executive Officer	Aug 18 '23	Sale	2.79	4,055	11,313	891,883	Aug 21 05:00 PM
Brainard Diana	Chief Executive Officer	Aug 17 '23	Sale	2.50	11,361	28,351	895,938	Aug 21 05:00 PM
Sinha Vikas	See Remarks	Aug 17 '23	Sale	2.50	10,516	26,243	1,173,701	Aug 21 05:00 PM
Hagen Brett R	Chief Accounting Officer	Aug 17 '23	Sale	2.50	1,653	4,125	127,175	Aug 21 05:00 PM
Sinha Vikas	See Remarks	Jul 20 '23	Sale	3.35	1,437	4,810	1,184,217	Jul 21 05:00 PM
Hagen Brett R	Chief Accounting Officer	Jul 20 '23	Sale	3.35	342	1,145	128,828	Jul 21 05:00 PM
Brainard Diana	Chief Executive Officer	Jul 19 '23	Sale	3.56	8,342	29,710	907,299	Jul 21 05:00 PM
Sinha Vikas	See Remarks	Jul 19 '23	Sale	3.56	1,198	4,267	1,185,654	Jul 21 05:00 PM
Hagen Brett R	Chief Accounting Officer	Jul 19 '23	Sale	3.56	342	1,218	129,170	Jul 21 05:00 PM
Brainard Diana	Chief Executive Officer	Jul 05 '23	Sale	3.05	5,275	16,063	915,641	Jul 06 05:00 PM
Sinha Vikas	See Remarks	Jul 05 '23	Sale	3.05	2,983	9,084	1,186,852	Jul 06 05:00 PM
GILEAD SCIENCES, INC.	10% Owner	Jun 27 '23	Buy	3.75	2,930,870	10,990,762	16,635,286	Jun 28 05:17 PM
Hagen Brett R	Chief Accounting Officer	Jun 09 '23	Sale	5.64	5,045	28,453	129,512	Jun 13 05:00 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

EOSE

Eos Energy Enterprises Inc

ALVR

AlloVir Inc

Upgrade your FINVIZ experience